Results 191 to 200 of about 4,730,453 (227)

Iron accumulation in the corpus callosum: a quantitative MRI study in relapsing-remitting multiple sclerosis. [PDF]

Ir J Med Sci
Al-Radaideh A, Almuqbel MM, Abousrafa S, Radaideh A, Hbahbih M.   +4 more
europepmc   +1 more source

Workplace difficulties in early-stage relapsing-remitting multiple sclerosis with low physical disability. [PDF]

Mult Scler J Exp Transl Clin
Pérez-Sempere Á, García-Arcelay E, Caruncho J, Candeliere-Merlicco A, Orviz A, Martín-Martínez J, Morales RP, Álvarez-Rodríguez E, Pacheco EM, Borrega L, Casanova I, Caminero AB, Sánchez-Menoyo JL, Gómez-Gutiérrez M, Carmona O, Calles C, Hernández MA, López-Muñoz P, González-Suárez I, Joly H, Maurino J.   +20 more
europepmc   +1 more source

Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis. [PDF]

Front Immunol
Buhelt S, Hansen MB, Søndergaard HB, El Mahdaoui S, Hansen MM, Mahler MR, Romme Christensen J, Sellebjerg F.   +7 more
europepmc   +1 more source

Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing-remitting multiple sclerosis: a case-control study. [PDF]

Front Neurol
Sarıdaş F, Aydın B, Özpar R, Koç ER, Hakyemez B, Alkan T, Turan ÖF.   +6 more
europepmc   +1 more source

The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosis. [PDF]

J Neuroinflammation
Marastoni D, Eccher C, Signori A, Anni D, Foschi M, Crescenzo F, Mazziotti V, Virla F, Sicchieri M, Turano E, Tamanti A, Camera V, Ziccardi S, Zanetti G, Pizzini FB, Martini S, Fratucello A, Bonetti B, Sormani MP, Calabrese M.   +19 more
europepmc   +1 more source

Immunogenicity of Hepatitis B Virus Vaccination in Relapsing-Remitting Multiple Sclerosis Patients Under Immunocompromising Treatment. [PDF]

Int J Mol Sci
Cruces-Párraga J, Muñoz-Jurado A, Escribano BM, Martín-Hersog FA, Triguero-Ortiz C, Carmona-Medialdea C, Túnez I, Caballero-Villarraso J, Agüera-Morales E.   +8 more
europepmc   +1 more source

Relapsing-Remitting Multiple Sclerosis Is Associated With a Dysbiotic Oral Microbiome. [PDF]

Ann Clin Transl Neurol
Ganesan SM, Yadav M, Ghimire S, Lehman PC, Patel AJ, Woods S, Olalde H, Hoang J, Paullus M, Cherwin C, Gill C, Cho T, Mangalam AK.   +12 more
europepmc   +1 more source

A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis. [PDF]

Eur J Epidemiol
Verweij S, Bijlsma MJ, Oude Rengerink K, Hillert J, Forsberg L, Mouresan EF, Glaser A, Fox RJ, Hak E, Mol P.   +9 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study. [PDF]

Eur J Neurol
Savolainen M, Soilu-Hänninen M, Nurmi H, Viitala M, Tienari P, Atula S, Laakso SM.   +6 more
europepmc   +1 more source

Oxidative stress, depressive symptoms, disability, cognitive outcomes and hand dexterity in relapsing-remitting multiple sclerosis patients with mild/moderate disability. [PDF]

IBRO Neurosci Rep
Mosaddeghi-Heris R, Taheri N, Talebi M, Naseri A.   +3 more
europepmc   +1 more source